7Rezkalia S H, Kloner R A.No-reflow phenomenon [J].Cireulation, 2002( 105 ) : 656-662.
8Lincoff A M, Califf R M, Vande Wed F, et al.Mortality at 1 year with combination platelet glycoprotein IIb,rIIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibri- nolytic therapy for acute myocardial infarctioon:GUSTO V Randomized Trial [ J ].JAMA, 2002,288 ( 17 ) : 2130-2135.
9Petronio A S, Rovai D, Musumeci G, et al.Effects of abcix- imab on microvascular integrity and left ventricular function- al vecovery in patients with acute infarction treated by pri- mary coronary angioplasty[J].Eur Heart J,2003, 24:67-76.
10Kawano H,Hayashida T,Ohtani H,et al.Histopathological findings of the no-reflow phenomenon following coronary in- tervention for acutecoronary syndrome [J].Int Heart J,2005, 46(2) :327-332.
